Magdalena K Bielecka

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Pulmonary Tuberculosis

Top Venues

Cytoskeleton (Hoboken, N.J.)

Antibiotics (Basel, Switzerland)

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Vincenzo Torraca, Magdalena K Bielecka, Margarida C Gomes, Dominik Brokatzky, Elisabeth M Busch-Nentwich, Serge Mostowy
Zebrafish null mutants of Sept6 and Sept15 are viable but more susceptible to Shigella infection. Cytoskeleton (Hoboken, N.J.) (2023)
Margarida C Gomes, Dominik Brokatzky, Magdalena K Bielecka, Fiona C Wardle, Serge Mostowy
Shigella induces epigenetic reprogramming of zebrafish neutrophils. Science advances 9 (36) (2023)
Vincenzo Torraca, Magdalena K Bielecka, Margarida C Gomes, Dominik Brokatzky, Elisabeth M Busch-Nentwich, Serge Mostowy
Zebrafish null mutants of Sept6 and Sept15 are viable but more susceptible to Shigella infection. Cytoskeleton (Hoboken, N.J.) (2023)
Ximena Gonzalo, Magdalena K Bielecka, Liku Tezera, Paul T Elkington, Francis Drobniewski
Anti-Tuberculosis Activity of Three Carbapenems, Clofazimine and Nitazoxanide Using a Novel Ex Vivo Phenotypic Drug Susceptibility Model of Human Tuberculosis. Antibiotics (Basel, Switzerland) 11 (10) (2022)
Hoan Van Ngo, Stevens Robertin, Dominik Brokatzky, Magdalena K Bielecka, Damián Lobato-Márquez, Vincenzo Torraca, Serge Mostowy
Septins promote caspase activity and coordinate mitochondrial apoptosis. Cytoskeleton (Hoboken, N.J.) (2022)